Cyrus Biotechnology is a privately held company based in Seattle, Washington. It offers protein modeling and design capabilities to the biotechnology, pharmaceutical, chemical, consumer products, and synthetic biology industries. The company's primary product is Cyrus Bench, a software package based on Rosetta, a protein-modeling platform created at the University of Washington.
This Software-as-a-Service (SaaS) product is a platform for protein structure prediction via homology modeling, protein modeling, protein stabilization, protein engineering, and protein design for biologics and small molecules. In July 2018, Cyrus announced that it would release a new immune screening and prediction tool in the platform.
The company's clients include 10 of the top 20 Global Pharmaceutical firms as well as several smaller biotechnology and chemical firms. Cyrus is financed by several technology and biotechnology investors, including Trinity Ventures, Orbimed, Springrock Ventures, Alexandria Venture Investments, the W Fund, and more.
Cyrus Biotechnology raises a $8,000,000 series A round from OrbiMed Advisors, Springrock Ventures, Trinity Ventures, W Fund and OrbiMed.
Craig W Philips
Scientific Co-Founder & Advisor
Director of Customer Experience and Senior Fellow
VP of Engineering
Founder & Chief Technical Officer
Founder & CEO
Executive VP of Sales
Founder & Chief Scientific Officer